Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

ZBH · Zimmer Biomet Holdings, Inc.

$97.44 -1.14% Oct 26 close
Detected setup Falling Wedge · Setup Score 54/100

Stand aside — setup invalidated

Setup score 54, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about ZBH

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$ZBH

Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $19B.

Health Technology Medical Specialties stock Stage 3 · Topping Base 1
$97.44 latest close
Market Structure
Trend structure: range
Latest event: bos (bearish)
Support 85.33–86.01 · 4 touches · moderate
Support 91.07–91.45 · 4 touches · moderate
Support 95.31–95.48 · 3 touches · moderate
Resistance 101.49–102.12 · 3 touches · moderate
Support 88.49–89.02 · 3 touches · moderate
Verdict · setup score 54/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 54, but distribution days reach 5 or more — stand aside until the condition resets.

Recent price action · daily
$90.00$100AugSepOct$97.44

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 1.2 150-day MA > 200-day MA — MA150 $91.34 vs MA200 $91.52
  • Minervini 1.8 RS rank ≥ 70 (prefer ≥ 85) — RS rank 52
  • O'Neil L: RS rank ≥ 80 (IBD leadership) — RS rank 52
  • O'Neil A: Annual earnings & revenue quality — Rev +7.2%
  • Weinstein Stage 2 (Advancing phase) confirmed — Stage 3 (Topping)
  • Weinstein Relative strength ≥ 60 — RS 52
Minority view — the council disagrees here
  • Minervini: avoid Trend-template read: fails 150-day MA > 200-day MA.
  • O'Neil: avoid CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).
  • Weinstein: avoid Stage-analysis read: topping (Stage 3) is not an advancing Stage 2.
54 Neutral
Legend Score · rates the stock Neutral (54/100) — held back by quality (smr-like)

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 52
  • Trend Template (25%) 62
  • Institutional Footprint (20%) 66
  • EPS Growth (15%) 50
  • Quality (SMR-like) (15%) 30

RS rank 52: middle of the pack — no leadership yet. Trend template 5/8: mixed — some uptrend elements, some missing. Institutional score 66: mild accumulation. No recent earnings growth data — scored neutral. Quality 30: weak fundamentals (sales growth 30). Updated 2026-10-27.

Earnings

Pre-earnings setup

Next earnings Tuesday, November 3, 2026 Before market open Exact clock time not supplied by source

Deterministic evidence

ZBH-1.14%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. ZBH was -1.14 points vs XLV. -1.85 points vs SPY.
CatalystPending Stock reactionNegative Sector reactionWeak Opening surgePending Event riskEarnings-driven

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close-1.14% From the open-0.27% Range position54% GapNo gap
QQQ confirmationDiverging (+1.11%) SMH confirmationDiverging (+2.74%)
Short-term conviction -2 points.
  • QQQ, SMH moved against the stock — no index confirmation.
  • A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $97.44 -1.1% Oct 26 close
52W High $104.15 6.4% below high
Wks Since High 50w
Base Depth 24.0%
RS Rank 15 percentile of scan
SMA 50 $95.10
Avg Vol 1,874,042
Rel Vol (Oct 26) 1.43× 1.10× on up days
More stats
52W Low $79.12
Tight Wks 1
Base B1
SMA 200 $91.52
RS Line vs High -16.7%
RS Line Slope +6.5% ▲
Group Rank #21/66
ADR% 2.3%
ATR(14) $2.33 (2.4%)
Vol Pace (live) N/A
A/D Days 18A / 18D
A/D Rating C
VDU Bars 0/10 d
Earnings in 7d
Position in 52-week range 73rdpercentile of the 52-week range
$79.12low
$104.15high

ZBH Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for ZBH.

Create Free Account

Technical Analysis Report Card

$ZBH · $97.44 · as of 2026-10-26 · multi-factor read
81
/ 100
Technicals 81/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▲ Uptrend

Moving Averages

50-day$95.10 ↑
100-day$93.28 ↑
200-day$91.52 ↑
Bullish (50 > 200)

RSI (14)

Reading60.0 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish
Histogram+0.955

Bullish — MACD above its signal line and above zero. Histogram contracting.

Bollinger Bands (20,2)

%B / Width85% · 15.3%

Near the upper band — buyers in control.

Volume · Buyer vs Seller

Up/Down vol1.1 · Neutral
Rel volume1.43×
Pocket pivots · 10d0
5d vs 50d vol98%
Heavy vol up / down0 / 0

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $97.70swing level
R · $99.18swing level
R · $102.41swing level
Price · $97.44now
S · $94.28swing level
S · $91.45swing level
S · $87.49swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$97.26
38.2%$93.79
50.0%$90.99
61.8%$88.19
78.6%$84.20

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for ZBH — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Monthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about ZBH
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (54/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 5 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Avoid D Trend-template read: fails 150-day MA > 200-day MA.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $97.44, MA150 $91.34, MA200 $91.52
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $95.10, MA150 $91.34, MA200 $91.52
Failing evidence
1.2 150-day MA > 200-day MAMA150 $91.34 vs MA200 $91.52
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 52
6/13 checks
O'Neil Avoid D CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).
Passing evidence
C: Quarterly EPS acceleration ≥ 25%CANSLIM grade B
N: Near 52-week high or RS line new high6.4% below high | RS line new high: False
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 52
A: Annual earnings & revenue qualityRev +7.2%
4/8 checks
Weinstein Avoid C Stage-analysis read: topping (Stage 3) is not an advancing Stage 2.
Passing evidence
Price above 30-week MA (200-day proxy)Price $97.44 vs MA200 $91.52
30-week MA trending upwardFrom weekly scan context
Failing evidence
Stage 2 (Advancing phase) confirmedStage 3 (Topping)
Relative strength ≥ 60RS 52
4/7 checks
dennis Watch B Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.
Passing evidence
No breakdown below the 20-day channel20-day low $87.11
Volatility-unit sizing (1N ≈ 1% of equity)1N = $2.51 (2.58% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
6/8 checks
zanger Avoid D Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $112.06-$116.93; trail the rest
Trail on the 10/20-day MA10-day MA $95.39 · 20-day MA $92.52 — exit the remainder on a close below the trail
Failing evidence
Named Zanger pattern onlyFalling Wedge is not one of Zanger's six
Not extended (≤5% above the breakout point)Not confirmed
3/6 checks
zweig Watch D Zweig read: part of his screen passes but not all: Insider buying; Price strength (RS ≥ 70) — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 27.4x — no PEG or forward P/E stored
Breadth momentum: 10-day A/D ratio10-day A/D 1.17 (2025 adv / 1725 dec) — participation expanding
Failing evidence
Insider buyingNo insider buying flagged
Price strength (RS ≥ 70)RS score 52 — Zweig buys strength, not bargains
3/8 checks
Livermore Watch B Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$97.44
Volume vs average1.43x
Failing evidence
Relative strengthRS 52
5/6 checks
Darvas Watch B Box-theory read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$97.44
Volume vs average1.43x
Failing evidence
Relative strengthRS 52
5/6 checks
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$97.44
Volume vs average1.43x
Failing evidence
Relative strengthRS 52
5/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
85RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +4 C
A: 17 D: 13 Net: +465 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 1/7 met
D 1/7 criteria
Separate score from the Minervini Trend Template (5/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ —
✗ Revenue growth ≥20% YoY +7%
✗ Gross margin ≥30% —
✗ ROE ≥17% —
✗ RS rating ≥80 (leadership) 52
✗ Stage 2 uptrend (Weinstein) Stage 3
✓ Within 25% of 52W high -6.4%

Method Playbook

Trade it like Zweig EXACT LEVELS · PRO
Zweig D · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the stock's recent consolidation high — Zweig buys strength in screened growers, not breakdowns.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Buy only when the growth screen passes: EPS growth above the market, PEG ≤ 1.5 (reasonable for the growth), insider buying, and RS leadership.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Define the loss before entry — Zweig's risk rule. Sell when the growth story breaks: earnings decelerate or the valuation stretches past reason.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Hold winners as long as earnings keep growing and the price holds its trend; sell half on a climax run.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when EPS growth falls below the market, the PEG stretches past reason, insiders stop buying — or the Super Model flips the market to defensive.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Forming Patterns (predictive — not confirmed)

Cup & Handle bullish early
60% built

Cup base building — 66% of the 15%-deep cup recovered. Watch for the right side to reach ~102.86, then a handle.

Confirms above 102.86
Invalidates at 94.98
Rim 102.86
Cup Low 87.11
Pivot 102.86
Mid Cup 94.98

Cup depth 15%, recovery 66%, handle=not yet

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

Falling Wedge ⚠ Extended past buy zone ⚠ Not actionable yet
54 setup score
RS Score 52
Trend template 5/8
CANSLIM 66.1* (B)
upper slope: -0.4743 lower slope: -0.1968 depth: 0.0079 narrowing ratio: 0.03 prior decline: 0.147 upper touches: 3 lower touches: 3 vol declining: ✗ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly trend template 5/8 confirmed
Why This Setup? D+W Confluence
Falling Wedge · schematic

prior_decline=14.7%, converging=yes, narrowing=3%, touches=upper:3/lower:3, near_upper=yes | Moderate trend (5/8) | High-confidence pattern (70%) | Readiness 43/100 (early) | CANSLIM 66.1 (B) | ⚠ Extended past buy zone; Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

3/7 universals met
  • A relative-strength leader — not met RS rank 15 — laggard
  • Clear of earnings — not met in 7 days — event risk
  • Not chasing (in range) — not met Not met — levels are a Pro detail
  • In a confirmed uptrend — partly met Stage 3 · Trend template 5/8 — not yet Stage 2
  • Asymmetric reward — met Met — levels are a Pro detail
  • Risk is defined — met Met — levels are a Pro detail
  • Volume confirms — met 1.4× average
Why these seven? → The Universal Edge

Minervini Trend Template

5/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $97.44 vs SMA150 $91.34 / SMA200 $91.52
SMA 150 above SMA 200 SMA150 $91.34 vs SMA200 $91.52
SMA 200 trending up Slope +0.12 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $95.10
Price above SMA 50 $97.44 vs SMA50 $95.10
30%+ above 52-week low +23.2% from $79.12
Within 25% of 52-week high -6.4% from $104.15
RS score above 70 RS 52

Fundamentals

52W Range
73%
Mkt Cap SEC
18.6B
Rev YoY
+7%
EPS TTM
$3.55
P/E TTM
27.4x
Float
191M
Insider
No Buy

Company

Company profile
Zimmer Biomet Holdings, Inc.
ZBH · NYSE · Health Technology · Medical Specialties
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 66.1* CANSLIM * disqualified on M
C · Curr. EPS
70
A · Annual EPS
64
N · New Highs
100
S · Supply/Demand
100
L · Leader RS
52
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
5/8
W. RS
59
W. Support
$79.12
W. Resist
$102.86
W. Patterns
Cup & Handle Basing
Weekly Structure

Scan History

20× streak
Oct 23: 55 (Falling Wedge)Oct 26: 55 (Falling Wedge)Oct 27: 54 (Falling Wedge)Oct 27: 55 (Falling Wedge)55
Oct 27
Falling Wedge
55
Oct 27
Falling Wedge
54
Oct 26
Falling Wedge
55 0.0%
Oct 23
Falling Wedge
55 -1.1%

Latest News

Headlines for ZBH
Loading headlines…

Get the full picture on ZBH

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial